COMT and SCN9A gene variants do not contribute to chronic low back pain in Mexican-Mestizo patients

Acta Neurochir (Wien). 2024 Feb 8;166(1):73. doi: 10.1007/s00701-024-05937-y.

Abstract

Background: Chronic low back pain (CLBP) is a complex condition in which genetic factors play a role in its susceptibility. Catechol-O-methyltransferase (COMT) and sodium channel NaV1.7 (SCN9A) genes are implicated in pain perception. The aim is to analyze the association of COMT and SCN9A with CLBP and their interaction, in a Mexican-Mestizo population.

Methods: A case-control study was conducted. Cases corresponded to adults of both sexes with CLBP. Controls were adults with no CLBP. Variants of SCN9A and COMT were genotyped. Allelic and genotypic frequencies and Hardy-Weinberg equilibrium (HWE) were calculated. Association was tested under codominant, dominant, and recessive models. Multifactor dimensionality reduction was developed to detect epistasis.

Results: Gene variants were in HWE, and there was no association under different inheritance models in the whole sample. In women, in codominant and dominant models, a trend to a high risk was observed for AA of rs4680 of COMT (OR = 1.7 [0.5-5.3] and 1.6 [0.7-3.4]) and for TT of rs4633 (OR = 1.6 [0.7-3.7] and 1.6 [0.7-3.4]). In men, a trend to low risk was observed for AG genotype of rs4680 in the same models (OR = 0.6 [0.2-1.7] and 0.7 [0.3-1.7]), and for TC genotype of rs4633 in the codominant model (OR = 0.6 [0.2-1.7]). In the interaction analysis, a model of the SCN9A and COMT variants showed a CVC of 10/10; however, the TA was 0.4141.

Conclusion: COMT and SCN9A variants are not associated with CLBP in the analyzed Mexican-Mestizo population.

Keywords: COMT; Epistasis; Gene variants; Genetics; Low back pain; SCN9A.

MeSH terms

  • Adult
  • Case-Control Studies
  • Catechol O-Methyltransferase* / genetics
  • Female
  • Humans
  • Low Back Pain* / genetics
  • Male
  • NAV1.7 Voltage-Gated Sodium Channel* / genetics

Substances

  • Catechol O-Methyltransferase
  • COMT protein, human
  • NAV1.7 Voltage-Gated Sodium Channel
  • SCN9A protein, human